WHO approves first mpox diagnostic test for emergency use, boosting global access

By Michael Gwarisa The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing. The approval for emergency use of the Alinity m MPXV assay, manufactured by Abbott Molecular Inc., will be pivotal in expanding diagnostic capacity in countries facing mpox outbreaks, where the need for quick and accurate testing has risen sharply. Early diagnosis of mpox enables timely treatment and care, and control of the virus. Limited testing capacity…

Read More

#BREAKING: WHO Hints On Declaring Mpox Public Health Emergency Of International Concern

By Michael Gwarisa WORLD Health Organisation (WHO) Director General, Dr Tedros Adhanom Ghebreyesus has warned of a more deadly and highly infectious Mpox strain spreading across Africa and other parts of the world. This follows revelations that the mpox outbreak that has been raging in the Democratic Republic of Congo (DRC) over the past several months might have spilled beyond the DRC borders. A report by science publication www.science.org shows that sequencing of the mpox viruses in three cases reported earlier this week in Uganda and Kenya has now confirmed…

Read More

COVID-19 no longer a Public Health Emergency of International Concern……WHAT DOES THIS MEAN?

FOR the past three years, the world literally came to a halt at the back of a raging COVID-19 pandemic that claimed and infected millions of people. According data, globally, as of 7 May 2023, over 765 million confirmed cases and over 6.9 million deaths had been reported to the World Health Organisation (WHO). By Michael Gwarisa Compared to other pandemics that have been experienced in the history of public health, COVID-19 has the least fatalities. For example, HIV and AIDS known as the human immunodeficiency virus (HIV), acquired immunodeficiency…

Read More